BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15160346)

  • 1. Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000: analysis of 1365 patients in a single institution in Japan.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Hayashi K; Honda T; Kitabatake S; Kuzuya T; Nonogaki K; Kasugai T; Shimizu J
    Cancer; 2004 Jun; 100(11):2415-21. PubMed ID: 15160346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal treatment strategy for elderly patients with hepatocellular carcinoma.
    Dohmen K; Shirahama M; Shigematsu H; Irie K; Ishibashi H
    J Gastroenterol Hepatol; 2004 Aug; 19(8):859-65. PubMed ID: 15242487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of surveillance on survival of patients with initial hepatocellular carcinoma: a study from Japan.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
    Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1170-6. PubMed ID: 16890027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
    Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
    J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in clinical characteristics, treatment and prognosis of hepatocellular carcinoma.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):1872-7. PubMed ID: 14696422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients.
    Zeng ZC; Tang ZY; Fan J; Qin LX; Ye SL; Zhou J; Sun HC; Wang BL; Wang JH
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1067-76. PubMed ID: 15913915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival improvement in Child-Pugh C cirrhotic patients with hepatocellular carcinoma diagnosed during 1990-2002.
    Ollivier I; Dauvois B; Guittet L; Boutreux S; Dupont B; Launoy G; Dao T
    Gastroenterol Clin Biol; 2010; 34(4-5):288-96. PubMed ID: 20189339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time.
    Yoo HY; Patt CH; Geschwind JF; Thuluvath PJ
    J Clin Oncol; 2003 Dec; 21(23):4329-35. PubMed ID: 14581446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
    Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
    J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Yamasaki T; Kimura T; Kurokawa F; Aoyama K; Ishikawa T; Tajima K; Yokoyama Y; Takami T; Omori K; Kawaguchi K; Tsuchiya M; Terai S; Sakaida I; Okita K
    J Gastroenterol; 2005 Jan; 40(1):70-8. PubMed ID: 15692792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative combined with postoperative chemoembolization can improve survival in patients with hepatocellular carcinoma: a single-center study.
    Liu Y; Yang R
    J Vasc Interv Radiol; 2009 Apr; 20(4):472-83. PubMed ID: 19250841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
    Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
    J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and prognosis of patients with hepatocellular carcinoma after the year 2000 in Japan.
    Toyoda H; Kumada T; Tada T; Sone Y; Kaneoka Y; Maeda A
    J Gastroenterol Hepatol; 2011 Dec; 26(12):1765-71. PubMed ID: 21615793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term trends and geographic variations in the survival of patients with hepatocellular carcinoma: analysis of 11,312 patients in Taiwan.
    Chen CH; Su WW; Yang SS; Chang TT; Cheng KS; Lin HH; Wu SS; Lee CM; Changchien CS; Chen CJ; Sheu JC; Chen DS; Lu SN
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1561-6. PubMed ID: 16928217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
    Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
    J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus.
    Thuluvath PJ; Maheshwari A; Thuluvath NP; Nguyen GC; Segev DL
    Liver Transpl; 2009 Jul; 15(7):754-62. PubMed ID: 19562709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Peng ZW; Zhang YJ; Chen MS; Liang HH; Li JQ; Zhang YQ; Lau WY
    Surg Oncol; 2008 Jul; 17(1):23-31. PubMed ID: 17869095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China.
    Zhou J; Fan J; Wu ZQ; Qiu SJ; Huang XW; Yu Y; Wang Z; Sun J; Xiao YS; He YF; Yang GH; Song K; Yuan Z; Wang YQ; Tang ZY
    Chin Med J (Engl); 2005 Apr; 118(8):654-9. PubMed ID: 15899120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.